Glimmer of hope emerges in pilot trial of people with mild cognitive impairment ...
Lithium—a decades-old treatment for bipolar disorder—may hold potential neuroprotective benefits beyond mood stabilization.
A clinical trial suggests that low-dose lithium may slow the decline of verbal memory in older adults with mild cognitive impairment and amyloid-beta.
A pilot clinical trial has found that low-dose lithium tablets might help slow verbal decline among seniors with mild ...
Lithium (Li⁺) remains a foundational treatment in psychiatry, particularly for bipolar disorder, manic episodes, and suicide prevention in major depressive ...
A once-daily dose of a medication, which averaged 195 mg, produced blood levels significantly lower than those typically pursued by psychiatrists. However, it succeeded in generating a weak signal ...
A study published in Nature on August 6, 2025, found that lithium is the only metal significantly depleted in the prefrontal ...